Lutathera Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET
Neuroendocrine TumorsProgressive DiseaseIntestinal Well Differentiated Endocrine Tumor
Institut du Cancer de Montpellier - Val d'Aurelle146 enrolled28 locationsNCT04954820
Recruiting
Phase 1
Lutathera and ASTX727 in Neuroendocrine Tumours
Neuroendocrine Tumors
Imperial College London27 enrolled1 locationNCT05178693
Recruiting
Phase 1
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
Gastroenteropancreatic Neuroendocrine Tumor
Stanford University10 enrolled1 locationNCT04609592